These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28950920)

  • 41. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment.
    Hirao K; Yamashita F; Sakurai S; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    Geriatr Gerontol Int; 2021 Aug; 21(8):644-650. PubMed ID: 34105230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of night-time blood pressure on cerebral white matter hyperintensity in elderly hypertensive patients.
    Kokubo M; Shimizu A; Mitsui T; Miyagi M; Nomoto K; Murohara T; Toba K; Sakurai T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():59-65. PubMed ID: 26671159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease.
    Li Q; Su S; Feng Y; Jia M; Zhan J; Liao Z; Li J; Li X;
    Alzheimers Dement; 2024 Jul; 20(7):4891-4902. PubMed ID: 38895921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression?
    Oudega ML; Siddiqui A; Wattjes MP; Barkhof F; Kate MT; Muller M; Bouckaert F; Vandenbulcke M; De Winter FL; Sienaert P; Stek ML; Comijs HC; Korten NCM; Emsell L; Eikelenboom P; Rhebergen D; van Exel E; Dols A
    J Geriatr Psychiatry Neurol; 2021 Jan; 34(1):21-28. PubMed ID: 32036772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.
    Tosto G; Zimmerman ME; Carmichael OT; Brickman AM;
    JAMA Neurol; 2014 Jul; 71(7):872-7. PubMed ID: 24821476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
    Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
    Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
    Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive performance in community-dwelling older adults with stroke and the contribution of age and diffuse subcortical damage: a population-based study in rural Ecuador (The Atahualpa Project).
    Del Brutto OH; Mera RM; Zambrano M; Lama J
    Aging Clin Exp Res; 2015 Oct; 27(5):647-52. PubMed ID: 25724660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Executive dysfunction assessed by Clock-Drawing Test in older non-demented subjects with metabolic syndrome is not mediated by white matter lesions.
    Viscogliosi G; Chiriac IM; Andreozzi P; Ettorre E
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):620-9. PubMed ID: 25781474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension.
    Jiménez-Balado J; Riba-Llena I; Abril O; Garde E; Penalba A; Ostos E; Maisterra O; Montaner J; Noviembre M; Mundet X; Ventura O; Pizarro J; Delgado P
    Hypertension; 2019 Feb; 73(2):342-349. PubMed ID: 30606062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower Cerebrovascular Reactivity Contributed to White Matter Hyperintensity-Related Cognitive Impairment: A Resting-State Functional MRI Study.
    Ni L; Zhang B; Yang D; Qin R; Xu H; Ma J; Shao P; Xu Y
    J Magn Reson Imaging; 2021 Mar; 53(3):703-711. PubMed ID: 32996183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Exploratory Study of Pathways from White Matter Hyperintensities to Cognitive Impairment through Depressive Symptoms Using Structural Equation Modeling: A Cross Sectional Study in Patients with Dementia.
    Lee CH; Kim DH
    J Int Neuropsychol Soc; 2020 Aug; 26(7):679-689. PubMed ID: 32183915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study.
    Yamawaki M; Wada-Isoe K; Yamamoto M; Nakashita S; Uemura Y; Takahashi Y; Nakayama T; Nakashima K
    Brain Behav; 2015 Mar; 5(3):e00315. PubMed ID: 25798332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Greater white matter hyperintensities and the association with executive function in suicide attempters with late-life depression.
    Lin C; Huang CM; Karim HT; Liu HL; Lee TM; Wu CW; Toh CH; Tsai YF; Yen TH; Lee SH
    Neurobiol Aging; 2021 Jul; 103():60-67. PubMed ID: 33845397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late-life Depression Modifies the Association Between Cerebral White Matter Hyperintensities and Functional Decline Among Older Adults.
    Hybels CF; Pieper CF; Payne ME; Steffens DC
    Am J Geriatr Psychiatry; 2016 Jan; 24(1):42-49. PubMed ID: 25863558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Confluent White Matter in Progression to Alzheimer Dementia.
    Heng LC; Lim SH; Foo H; Kandiah N
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):8-13. PubMed ID: 33009038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between white matter hyperintensity volume and cognitive/physical decline in older people with dementia: A one-year longitudinal study.
    Hairu R; Close JCT; Lord SR; Delbaere K; Wen W; Jiang J; Taylor ME
    Aging Ment Health; 2022 Dec; 26(12):2503-2510. PubMed ID: 34569854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.